According to a new report from Intel Market Research, the North America Intelligent Biotech Healthcare market was valued at USD 1.38 billion in 2025 and is projected to reach USD 3.16 billion by 2034, exhibiting a robust CAGR of 7.2 % during the forecast period (2026–2034). This growth is propelled by the convergence of artificial‑intelligence (AI) breakthroughs, escalating demand for...